AEM vs FMC

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

FMC Corporation is in a state of critical financial distress, evidenced by a Piotroski F-Score of 1/9 and a catastrophic 5-year price decline of 85.2%. While the stock appears cheap on a Price-to-Book (0.90) and Price-to-Sales (0.54) basis, these are classic 'value trap' indicators given the severe negative profit margin of -64.57% and an unsustainable dividend payout ratio of 223.08%. High leverage (Debt/Equity of 2.00) combined with declining revenue growth (-11.5% YoY) suggests significant operational instability.